MedCap AB (publ) (STO:MCAP)
Sweden
· Delayed Price · Currency is SEK 467.40
-10.80 (-2.26%)
Apr 28, 2026, 5:29 PM CET
MedCap AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 2,108 | 1,807 | 1,587 | 1,124 | 926.3 | Upgrade
|
| Other Revenue | 1.6 | 0.6 | 1.6 | 0.2 | - | Upgrade
|
| Revenue | 2,110 | 1,807 | 1,589 | 1,124 | 926.3 | Upgrade
|
| Revenue Growth (YoY) | 16.73% | 13.74% | 41.37% | 21.34% | 11.87% | Upgrade
|
| Cost of Revenue | 871.9 | 749.6 | 660.7 | 446.8 | 357.7 | Upgrade
|
| Gross Profit | 1,238 | 1,058 | 928.3 | 677.2 | 568.6 | Upgrade
|
| Selling, General & Admin | 791.5 | 698.5 | 601.1 | 443.5 | 384.6 | Upgrade
|
| Other Operating Expenses | 4.2 | 3 | 7.9 | 3.3 | 4.7 | Upgrade
|
| Operating Expenses | 949 | 816.9 | 712.1 | 528.1 | 464.8 | Upgrade
|
| Operating Income | 288.7 | 240.8 | 216.2 | 149.1 | 103.8 | Upgrade
|
| Interest Expense | -31.5 | -18.5 | -15.6 | -16.4 | -9.4 | Upgrade
|
| Interest & Investment Income | 5.1 | 8.3 | 7 | 2.3 | 0.4 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | 1.3 | Upgrade
|
| Currency Exchange Gain (Loss) | 17.4 | 5 | 14.7 | 2.8 | 1.7 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.1 | 0.2 | 0.1 | 0.1 | - | Upgrade
|
| EBT Excluding Unusual Items | 279.6 | 235.8 | 222.4 | 137.9 | 97.8 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 20 | 4 | Upgrade
|
| Asset Writedown | - | - | -0.9 | -6.5 | - | Upgrade
|
| Other Unusual Items | 9.4 | 25.7 | - | 0.6 | 15.1 | Upgrade
|
| Pretax Income | 289 | 261.6 | 222.3 | 152 | 117 | Upgrade
|
| Income Tax Expense | 68.3 | 52.3 | 49.8 | 34 | 18.9 | Upgrade
|
| Earnings From Continuing Operations | 220.7 | 209.3 | 172.5 | 118 | 98.1 | Upgrade
|
| Net Income to Company | 220.7 | 209.3 | 172.5 | 118 | 98.1 | Upgrade
|
| Minority Interest in Earnings | -0.9 | -1.9 | -0.3 | -0.4 | -1.6 | Upgrade
|
| Net Income | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 | Upgrade
|
| Net Income to Common | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 | Upgrade
|
| Net Income Growth | 5.98% | 20.44% | 46.43% | 21.87% | 58.46% | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | Upgrade
|
| Shares Change (YoY) | 0.94% | 0.05% | 0.33% | 0.04% | 3.10% | Upgrade
|
| EPS (Basic) | 14.67 | 14.00 | 11.63 | 7.94 | 6.52 | Upgrade
|
| EPS (Diluted) | 14.67 | 14.00 | 11.60 | 7.90 | 6.50 | Upgrade
|
| EPS Growth | 4.80% | 20.66% | 46.84% | 21.54% | 53.18% | Upgrade
|
| Free Cash Flow | 317 | 318.2 | 205.9 | 59.2 | 71 | Upgrade
|
| Free Cash Flow Per Share | 21.13 | 21.41 | 13.86 | 4.00 | 4.80 | Upgrade
|
| Gross Margin | 58.67% | 58.52% | 58.42% | 60.25% | 61.38% | Upgrade
|
| Operating Margin | 13.69% | 13.32% | 13.61% | 13.26% | 11.21% | Upgrade
|
| Profit Margin | 10.42% | 11.48% | 10.84% | 10.46% | 10.42% | Upgrade
|
| Free Cash Flow Margin | 15.03% | 17.61% | 12.96% | 5.27% | 7.66% | Upgrade
|
| EBITDA | 377.2 | 304.8 | 268.3 | 188.6 | 141.1 | Upgrade
|
| EBITDA Margin | 17.88% | 16.86% | 16.89% | 16.78% | 15.23% | Upgrade
|
| D&A For EBITDA | 88.5 | 64 | 52.1 | 39.5 | 37.3 | Upgrade
|
| EBIT | 288.7 | 240.8 | 216.2 | 149.1 | 103.8 | Upgrade
|
| EBIT Margin | 13.69% | 13.32% | 13.61% | 13.26% | 11.21% | Upgrade
|
| Effective Tax Rate | 23.63% | 19.99% | 22.40% | 22.37% | 16.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.